JACC. Cardiovascular interventions最新文献

英文中文

Transcatheter Valve-in-Valve Replacement After Transcatheter Tricuspid Valve Replacement 经导管三尖瓣置换术后的经导管瓣内置换术。

IF 11.4 1区医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS

JACC. Cardiovascular interventions

Pub Date : 2026-01-26 DOI: 10.1016/j.jcin.2025.11.020

Jiawei Zhou MD, Yuehuan Li MD, JianGang Wang MD, Haibo Zhang MD

引用次数: 0

TTVR in Large or Small Annuli 大环或小环的TTVR：我们知道的越多，我们害怕的就越少。

IF 11.4 1区医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS

JACC. Cardiovascular interventions

Pub Date : 2026-01-26 DOI: 10.1016/j.jcin.2025.11.014

Antonio Mangieri MD , Francesco Tartaglia MD

引用次数: 0

PFO Closure for Secondary Stroke Prevention in Patients >60 Years PFO关闭对60岁以下患者二级卒中预防的作用

IF 11.4 1区医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS

JACC. Cardiovascular interventions

Pub Date : 2026-01-26 DOI: 10.1016/j.jcin.2025.06.045

Anastasios Apostolos MD, MSc , Nikolaos Ktenopoulos MD, MSc , Ioannis Skalidis MD, PhD , Konstantinos Tsioufis MD, PhD , Konstantinos Toutouzas MD, PhD

引用次数: 0

Radiation Exposure to Operators in Coronary Procedures Between Left Distal and Right Conventional Radial Access 冠状动脉手术操作者在左远端和右常规桡动脉通路之间的辐射暴露。

IF 11.4 1区医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS

JACC. Cardiovascular interventions

Pub Date : 2026-01-26 DOI: 10.1016/j.jcin.2025.10.028

Oh-Hyun Lee MD , Ji Woong Roh MD, PhD , Yongcheol Kim MD, PhD , Seok-Jae Heo PhD , Sang Yeub Lee MD, PhD , Jung-Hee Lee MD, PhD , Eui Im MD , Deok-Kyu Cho MD

Background

Distal radial access (DRA) may improve vascular complications, patient comfort, and hemostasis time. DRA-associated operator radiation exposure data are limited.

Objectives

The aim of this study was to compare operator radiation exposure between left DRA and right transradial access (TRA).

Methods

In this prospective, multicenter, open-label trial, 1,010 patients scheduled to undergo coronary procedures were randomly assigned in a 1:1 ratio to either the left DRA or right TRA group. The primary endpoint was operator radiation exposure, measured using a set of 3 real-time radiation detection dosimeters on the left wrist, head, and chest by 5 experienced DRA operators. The secondary endpoints included the incidence of access-site crossover, total fluoroscopy time, total procedure time, and total contrast volume used.

Results

The primary endpoint analysis included 1,001 patients (501 in the left DRA group and 500 in the right TRA group). No significant differences were observed in operator radiation exposure to left wrist (4.76 μSv vs 5.20 μSv; P = 0.342), head (2.00 μSv vs 1.83 μSv; P = 0.416), and chest (1.28 μSv vs 1.07 μSv; P = 0.199) between the left DRA and right TRA groups. The incidence of crossover (6.6% vs 5.2%; P = 0.416), fluoroscopy time (4.5 minutes vs 4.2 minutes; P = 0.673), procedure time (16.0 minutes vs 15.0 minutes; P = 0.314), and contrast volume (80.0 mL vs 80.0 mL; P = 0.222) were not significantly different between the 2 groups.

Conclusions

During coronary procedures, no significant differences were observed in the operator radiation exposure at the left wrist, head, and chest between the left DRA and right TRA groups.

桡骨远端通路（DRA）可改善血管并发症、患者舒适度和止血时间。与dra相关的操作员辐射暴露数据是有限的。目的比较左桡动脉放射治疗（DRA）和右桡动脉放射治疗（TRA）的操作者辐射暴露情况。方法在这项前瞻性、多中心、开放标签的试验中，我们将1010名计划接受冠状动脉手术的患者按1:1的比例随机分配到左DRA组或右TRA组。主要终点是操作者的辐射暴露（μSv），由5名经验丰富的DRA操作者使用3套实时辐射检测剂量计在左手腕、头部和胸部测量。次要终点包括通路交叉发生率、总透视时间、总手术时间和使用的总造影剂体积。结果主要终点分析纳入1001例患者（左DRA组501例，右TRA组500例）。左、右TRA组操作者在左手腕（4.76 vs. 5.20 μSv， P=0.342）、头部（2.00 vs. 1.83 μSv， P=0.416）、胸部（1.28±vs. 1.07 μSv， P=0.199）的辐射暴露量差异无统计学意义。两组间交叉发生率（6.6% vs. 5.2%， P=0.416）、透视时间（4.5 vs. 4.2 min， P=0.673）、手术时间（16.0 vs. 15.0 min， P=0.314）、造影剂体积（80.0 vs. 80.0 mL， P=0.222）差异无统计学意义。结论在冠状动脉手术过程中，左DRA组和右TRA组的操作者在左手腕、头部和胸部的辐射暴露无显著差异。

{"title":"Radiation Exposure to Operators in Coronary Procedures Between Left Distal and Right Conventional Radial Access","authors":"Oh-Hyun Lee MD , Ji Woong Roh MD, PhD , Yongcheol Kim MD, PhD , Seok-Jae Heo PhD , Sang Yeub Lee MD, PhD , Jung-Hee Lee MD, PhD , Eui Im MD , Deok-Kyu Cho MD","doi":"10.1016/j.jcin.2025.10.028","DOIUrl":"10.1016/j.jcin.2025.10.028","url":null,"abstract":"<div><h3>Background</h3><div>Distal radial access (DRA) may improve vascular complications, patient comfort, and hemostasis time. DRA-associated operator radiation exposure data are limited.</div></div><div><h3>Objectives</h3><div>The aim of this study was to compare operator radiation exposure between left DRA and right transradial access (TRA).</div></div><div><h3>Methods</h3><div>In this prospective, multicenter, open-label trial, 1,010 patients scheduled to undergo coronary procedures were randomly assigned in a 1:1 ratio to either the left DRA or right TRA group. The primary endpoint was operator radiation exposure, measured using a set of 3 real-time radiation detection dosimeters on the left wrist, head, and chest by 5 experienced DRA operators. The secondary endpoints included the incidence of access-site crossover, total fluoroscopy time, total procedure time, and total contrast volume used.</div></div><div><h3>Results</h3><div>The primary endpoint analysis included 1,001 patients (501 in the left DRA group and 500 in the right TRA group). No significant differences were observed in operator radiation exposure to left wrist (4.76 μSv vs 5.20 μSv; <em>P</em> = 0.342), head (2.00 μSv vs 1.83 μSv; <em>P</em> = 0.416), and chest (1.28 μSv vs 1.07 μSv; <em>P</em> = 0.199) between the left DRA and right TRA groups. The incidence of crossover (6.6% vs 5.2%; <em>P</em> = 0.416), fluoroscopy time (4.5 minutes vs 4.2 minutes; <em>P</em> = 0.673), procedure time (16.0 minutes vs 15.0 minutes; <em>P</em> = 0.314), and contrast volume (80.0 mL vs 80.0 mL; <em>P</em> = 0.222) were not significantly different between the 2 groups.</div></div><div><h3>Conclusions</h3><div>During coronary procedures, no significant differences were observed in the operator radiation exposure at the left wrist, head, and chest between the left DRA and right TRA groups.</div></div>","PeriodicalId":14688,"journal":{"name":"JACC. Cardiovascular interventions","volume":"19 2","pages":"Pages 160-170"},"PeriodicalIF":11.4,"publicationDate":"2026-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145374024","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

The Prognostic Value of Right Ventricle–Pulmonary Artery Coupling in Valve Interventions 右心室-肺动脉耦合在瓣膜干预中的预后价值：系统回顾和荟萃分析。

IF 11.4 1区医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS

JACC. Cardiovascular interventions

Pub Date : 2026-01-26 DOI: 10.1016/j.jcin.2025.10.024

Vitaliy Androshchuk MBBCh , Edouard Long MSc , Omar Chehab MB BS , Natalie Montarello MB BS , Joshua Wilcox BM BS , Benedict McDonaugh MB BS , Ronak Rajani BM, MD , Philippe Pibarot DVM, PhD , Bernard Prendergast BM BS, MD , Tiffany Patterson MB BS, PhD , Simon Redwood MB BS, MD

Background

Right ventricle–pulmonary artery (RV-PA) coupling is prognostically important in valvular heart disease.

Objectives

The authors performed a systematic review and meta-analysis to quantify the association of RV-PA coupling with clinical endpoints after intervention for aortic stenosis (AS), mitral regurgitation (MR), and tricuspid regurgitation (TR).

Methods

The primary outcome was all-cause mortality, and the secondary outcome was a composite of major adverse cardiovascular events (MACE). A random-effects model was used to compute pooled effect estimates, and summary receiver-operating characteristic curves identified optimal RV-PA thresholds.

Results

In total, 30 interventional studies (N = 12,992) met eligibility criteria, including 14 AS (n = 6,100), 12 MR (n = 5,032), and 4 TR (n = 1,860) studies. Tricuspid annular plane systolic excursion (TAPSE) to pulmonary artery systolic pressure (PASP) was the most studied RV-PA coupling index. Reduced TAPSE/PASP was independently associated with all-cause mortality (AS adjusted HR: 1.69 [95% CI: 1.30-2.20]; MR adjusted HR: 1.94 [95% CI: 1.40-2.69]; P < 0.001) and the composite MACE (AS adjusted HR: 1.60 [95% CI: 1.29-2.00]; MR adjusted HR: 2.01 [95% CI: 1.54-2.62]; P < 0.001). There were significant nonlinear associations between TAPSE/PASP and adverse outcomes in AS and MR (P < 0.001). There were insufficient data to estimate a pooled effect-size in TR. Optimal TAPSE/PASP thresholds to predict all-cause mortality were ≤0.51 mm/mm Hg for AS interventions, ≤0.33 mm/mm Hg for MR interventions and ≤0.44 mm/mm Hg for TR interventions.

Conclusions

TAPSE/PASP is an independent predictor of outcomes after interventions for AS and MR. The disease-specific TAPSE/PASP cutoffs could be integrated into risk-stratification models to better predict mortality before valve interventions and improve patient selection.

背景：右心室-肺动脉（RV-PA）耦合在瓣膜性心脏病中具有重要的预后意义。目的：作者进行了一项系统回顾和荟萃分析，以量化主动脉瓣狭窄（AS）、二尖瓣反流（MR）和三尖瓣反流（TR）干预后RV-PA偶联与临床终点的关系。方法：主要结局为全因死亡率，次要结局为主要心血管不良事件（MACE）的综合结局。随机效应模型用于计算汇总效应估计，汇总接受者-操作特征曲线确定最佳RV-PA阈值。结果：总共有30项介入研究（N = 12,992）符合资格标准，包括14项AS (N = 6,100)， 12项MR （N = 5,032）和4项TR （N = 1,860）研究。三尖瓣环平面收缩偏移（TAPSE）与肺动脉收缩压（PASP）是研究最多的RV-PA耦合指标。降低的TAPSE/PASP与全因死亡率（AS校正后的HR: 1.69 [95% CI: 1.30-2.20]； MR校正后的HR: 1.94 [95% CI: 1.40-2.69]; P < 0.001）和综合MACE （AS校正后的HR: 1.60 [95% CI: 1.29-2.00]； MR校正后的HR: 2.01 [95% CI: 1.54-2.62]; P < 0.001）独立相关。TAPSE/PASP与AS和MR不良结局之间存在显著的非线性关联（P < 0.001）。预测全因死亡率的最佳TAPSE/PASP阈值为：AS干预≤0.51 mm/mm Hg， MR干预≤0.33 mm/mm Hg， TR干预≤0.44 mm/mm Hg。结论：TAPSE/PASP是AS和mr干预后预后的独立预测因子。疾病特异性的TAPSE/PASP临界值可以整合到风险分层模型中，以更好地预测瓣膜干预前的死亡率，并改善患者选择。

{"title":"The Prognostic Value of Right Ventricle–Pulmonary Artery Coupling in Valve Interventions","authors":"Vitaliy Androshchuk MBBCh , Edouard Long MSc , Omar Chehab MB BS , Natalie Montarello MB BS , Joshua Wilcox BM BS , Benedict McDonaugh MB BS , Ronak Rajani BM, MD , Philippe Pibarot DVM, PhD , Bernard Prendergast BM BS, MD , Tiffany Patterson MB BS, PhD , Simon Redwood MB BS, MD","doi":"10.1016/j.jcin.2025.10.024","DOIUrl":"10.1016/j.jcin.2025.10.024","url":null,"abstract":"<div><h3>Background</h3><div>Right ventricle–pulmonary artery (RV-PA) coupling is prognostically important in valvular heart disease.</div></div><div><h3>Objectives</h3><div>The authors performed a systematic review and meta-analysis to quantify the association of RV-PA coupling with clinical endpoints after intervention for aortic stenosis (AS), mitral regurgitation (MR), and tricuspid regurgitation (TR).</div></div><div><h3>Methods</h3><div>The primary outcome was all-cause mortality, and the secondary outcome was a composite of major adverse cardiovascular events (MACE). A random-effects model was used to compute pooled effect estimates, and summary receiver-operating characteristic curves identified optimal RV-PA thresholds.</div></div><div><h3>Results</h3><div>In total, 30 interventional studies (N = 12,992) met eligibility criteria, including 14 AS (n = 6,100), 12 MR (n = 5,032), and 4 TR (n = 1,860) studies. Tricuspid annular plane systolic excursion (TAPSE) to pulmonary artery systolic pressure (PASP) was the most studied RV-PA coupling index. Reduced TAPSE/PASP was independently associated with all-cause mortality (AS adjusted HR: 1.69 [95% CI: 1.30-2.20]; MR adjusted HR: 1.94 [95% CI: 1.40-2.69]; <em>P</em> < 0.001) and the composite MACE (AS adjusted HR: 1.60 [95% CI: 1.29-2.00]; MR adjusted HR: 2.01 [95% CI: 1.54-2.62]; <em>P</em> < 0.001). There were significant nonlinear associations between TAPSE/PASP and adverse outcomes in AS and MR (<em>P</em> < 0.001). There were insufficient data to estimate a pooled effect-size in TR. Optimal TAPSE/PASP thresholds to predict all-cause mortality were ≤0.51 mm/mm Hg for AS interventions, ≤0.33 mm/mm Hg for MR interventions and ≤0.44 mm/mm Hg for TR interventions.</div></div><div><h3>Conclusions</h3><div>TAPSE/PASP is an independent predictor of outcomes after interventions for AS and MR. The disease-specific TAPSE/PASP cutoffs could be integrated into risk-stratification models to better predict mortality before valve interventions and improve patient selection.</div></div>","PeriodicalId":14688,"journal":{"name":"JACC. Cardiovascular interventions","volume":"19 2","pages":"Pages 174-188"},"PeriodicalIF":11.4,"publicationDate":"2026-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145762883","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Knowing the Unknowns—HALT After TTVR Is Common 了解未知- TTVR后的停顿很常见

IF 11.4 1区医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS

JACC. Cardiovascular interventions

Pub Date : 2026-01-26 DOI: 10.1016/j.jcin.2025.11.026

João L. Cavalcante MD

引用次数: 0

Long-Term Clinical and Hemodynamic Outcomes of Transcatheter Mitral Valve Replacement 经导管二尖瓣置换术的长期临床和血流动力学结果

IF 11.4 1区医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS

JACC. Cardiovascular interventions

Pub Date : 2026-01-26 DOI: 10.1016/j.jcin.2025.10.016

Sergio Berti MD , Andreina D’Agostino MD , Edoardo Zancanaro MD

引用次数: 0

Takotsubo Syndrome and Coronary Physiology Takotsubo综合征与冠状动脉生理学

IF 11.4 1区医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS

JACC. Cardiovascular interventions

Pub Date : 2026-01-26 DOI: 10.1016/j.jcin.2025.06.044

Ioannis Skalidis MD, PhD , Grigorios Tsigkas MD, PhD , Nicolas Amabile MD, PhD , Grigoris V. Karamasis MD, PhD , Mariama Akodad MD, PhD

引用次数: 0

Pelvic Lead Apron Shielding During Transradial Approach 经桡骨入路时骨盆铅围裙屏蔽

IF 11.4 1区医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS

JACC. Cardiovascular interventions

Pub Date : 2026-01-26 DOI: 10.1016/j.jcin.2025.11.027

Ariel Roguin MD, PhD , Ofer M. Kobo MD, MHA

引用次数: 0

Facilitated Transcatheter Tricuspid Valve Edge-to-Edge Repair in Extreme IVC-TA Offset 经导管三尖瓣边缘到边缘修复在极端IVC-TA偏移。

IF 11.4 1区医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS

JACC. Cardiovascular interventions

Pub Date : 2026-01-26 DOI: 10.1016/j.jcin.2025.10.059

Polydoros N. Kampaktsis MD, PhD, Craig Basman MD, Vandan Upadhyaya MD, MBA, Sung-Han Yoon MD, Perry Wengrofsky MD, Vladimir Jelnin MD, Ryan Kaple MD

引用次数: 0

首页上一页

下一页尾页

类型

全部化学•材料生命科学医学物理工程技术环境•农林材料科学地球科学法学管理学化学环境科学与生态学计算机科学教育学经济学农林科学人文科学生物学数学物理与天体物理心理学综合性期刊其他工业工程理学历史学农学文学信息工程

数据库

全部 ACS Publications Elsevier ieeexplore Springer The Royal Society of Chemistry Wiley

期刊

JACC. Cardiovascular interventions

全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.

﹀